| Bioactivity | RORγt inverse agonist 28 is a potent reverse agonist of RORγt. RORγt inverse agonist 28 regulates the differentiation of Th17 cells and inhibits the production of IL-17. RORγt inverse agonist 28 has the potential for the research of inflammation and autoimmune diseases (extracted from patent WO2021228215A1, compound 6) [1]. |
| Name | RORγt inverse agonist 28 |
| CAS | 2741870-21-1 |
| Formula | C23H18Cl2F3NO5S |
| Molar Mass | 548.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yaobang Chen, et al. Biaryls as RORγ Modulators. Patent WO2021228215A1. |
RORγt inverse agonist 28
CAS: 2741870-21-1 F: C23H18Cl2F3NO5S W: 548.36
RORγt inverse agonist 28 is a potent reverse agonist of RORγt. RORγt inverse agonist 28 regulates the differentiation
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.